Skip to main content
Premium Trial:

Request an Annual Quote

LSBC Completes $8.2M Placement

NEW YORK, March 10 (GenomeWeb News) - Large Scale Biology today announced the completion of an $8.2 million private placement. The company sold 5.2 million new shares of common stock, and issued warrants with a five-year-term to purchase an additional 1.3 million shares.

 

Proceeds from the private placement will be used to fund product development; meet expected strategic partnership commitments; and facilitate short-term revenue streams, the company said.

 

Large Scale Biology in February reported a 38 percent drop in its fourth-quarter revenues, year over year, along with a drop in R&D spending and narrowed losses. The company had revenues of $621,000 for the quarter ended Dec. 31, 2003, down from $997,000 in the year-ago period.  LSBC's net loss for the period was $7.1 million, down from $7.3 million for the fourth quarter of 2002. As of Dec. 31, 2003, the company had $7.7 million in cash and marketable securities.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.